Data as of Dec 06
| -0.02 / -0.10%|
The 7 analysts offering 12-month price forecasts for PharMerica Corp have a median target of 20.00, with a high estimate of 21.00 and a low estimate of 14.00. The median estimate represents a -3.66% decrease from the last price of 20.76.
The current consensus among 7 polled investment analysts is to Buy stock in PharMerica Corp. This rating has held steady since November, when it was upgraded from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.